Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people lose relatively little weight in their first month on Wegovy. The 0.25 mg starting dose is there to let your body adjust, not to drive rapid results — so the first four weeks are less about the scales and more about tolerability. Average weight loss across the full trial period (68 weeks at the 2.4 mg maintenance dose) reached around 15% of body weight in the STEP 1 trial, published in the New England Journal of Medicine; early-month figures are a fraction of that. Wegovy is a prescription-only medicine, and a GPhC-registered prescriber must assess your suitability before any treatment begins, what you lose, and when, depends on your clinical picture, your lifestyle changes alongside it, and the dose your prescriber reaches over time.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first week often produces a noticeable drop on the scales. Some of that is fluid. The starter dose is calibrated to reduce side-effect risk, not to maximise fat loss, so treating the week-one figure as a template for the months ahead tends to lead to disappointment. If you want a clearer sense of what week one typically looks like, the numbers are more nuanced than the headlines suggest.
By the end of month one, most people have completed their first dose step and are either staying at 0.25 mg or moving to 0.5 mg under their prescriber's guidance. Appetite suppression is usually beginning to feel real by this point. Weight reduction in that window tends to sit in the range of 1–3 kg for many people, though this varies considerably with starting weight, diet changes and activity. The trial data reflects an average across thousands of participants over the full programme, and if you're wondering how much weight you can lose on Wegovy in the first month, individual results are much harder to pin down with precision than the headline averages suggest. Monthly averages across the Wegovy programme give you a fuller picture of how the curve typically builds.
One thing our prescribers hear regularly: people are surprised that the medicine works gradually. That's by design. The dose escalation over roughly four months exists to let the treatment settle into your routine, and to keep side effects manageable enough that you stay on it long enough for it to work.
UK private weight-loss treatment is priced per pen, per month, and it varies between providers by dose and by what's included in the headline figure. Eli Lilly raised Mounjaro's UK list price significantly from 1 September 2025, and private pricing across GLP-1 treatments has shifted in that context; understanding the Wegovy drug price and what drives it is useful background before comparing providers, though these figures move and should be treated as context rather than fixed quotes.
The more useful question is what a quoted price actually covers. Many providers charge separately for the clinical consultation, the prescription, and delivery. That means a lower headline number can end up costing more once those are added. On Wegovy pricing in the UK, the breakdown matters as much as the total. If aftercare (follow-up support between doses, clinical re-review before each repeat order) isn't included, that's a gap worth thinking about for a treatment that runs over months.
At nume, the price we quote includes the consultation, the prescription, the medicine, next-working-day tracked delivery, and 7-day aftercare. We don't offer subscriptions or auto-renewals; every repeat order is re-reviewed clinically before it goes out. You can see current treatment options at our consultation page. We aren't the cheapest option out there. That's a deliberate choice, the pricing reflects the infrastructure behind it, not a race to the bottom.
For a prescription-only medicine like Wegovy, the lowest price on a search results page answers the wrong question. The MHRA has issued public warnings about counterfeit weight-loss pens sold through social media and unverified online sellers, fake pens that in some cases have contained insulin rather than semaglutide. Checking that any pharmacy you use is registered on the GPhC register takes about thirty seconds and is the single most useful thing you can do before handing over payment details.
Sellers offering these medicines without a prescription, with no clinical review, or with discount codes attached are red flags rather than bargains. Legitimate pricing for a POM reflects the cost of a real prescriber reviewing your case, a regulated supply chain, and ongoing clinical oversight. A small saving on the pen is not worth the risk of a counterfeit product or a missed contraindication. You can report suspect sellers directly through the MHRA's Yellow Card scheme.
The pen itself sits in the fridge (most people keep it in the door, next to everyday things) and the routine of a weekly injection becomes unremarkable quickly. What doesn't become unremarkable quickly is discovering mid-treatment that your provider has no aftercare support, or that your next supply is delayed because there's no prescriber available to re-authorise. That's the practical cost of choosing on price alone. For a fuller picture of what treatment involves, our Wegovy overview covers the clinical detail.
The first month of Wegovy is really a starting point. The meaningful weight loss happens over the following months as the dose builds, appetite suppression deepens, and lifestyle habits settle around it. How much you lose per month across the programme follows a curve, not a flat line, and your experience will sit somewhere on that curve based on factors a prescriber considers during assessment.
If you're trying to decide whether to start, the consultation is the right next step, it's free, it's the same day, and it answers the question most people are actually asking: am I suitable, and what should I realistically expect? Our clinical team reviews every consultation personally. There are no algorithms involved, no automated approvals. Start your free consultation and get a clinical view on your specific situation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.